Amsacrine



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Acute Myeloid Leukaemia 43.5%
Product Used For Unknown Indication 13.9%
Prophylaxis 11.7%
Haematological Malignancy 6.3%
Infection 4.4%
Acute Leukaemia 3.4%
Allogenic Bone Marrow Transplantation Therapy 2.9%
Bronchopulmonary Aspergillosis 2.8%
Prophylaxis Of Nausea And Vomiting 1.5%
Immunosuppressant Drug Therapy 1.3%
Stem Cell Transplant 1.2%
Antifungal Prophylaxis 1.1%
Diabetes Mellitus 1.1%
Pyrexia 0.9%
Aspergillosis 0.8%
Cardiac Disorder 0.7%
Acute Promyelocytic Leukaemia 0.6%
Febrile Neutropenia 0.6%
Fungal Infection 0.6%
Hyperthermia 0.6%
Respiratory Failure 10.8%
Neutropenic Colitis 9.7%
Sepsis 7.5%
Complications Of Bone Marrow Transplant 6.5%
Thrombocytopenia 6.5%
Electrocardiogram Qt Prolonged 5.4%
Pancytopenia 5.4%
Cardiac Failure 4.3%
Cytolytic Hepatitis 4.3%
Febrile Neutropenia 4.3%
Infection 4.3%
Renal Failure 4.3%
Septic Shock 4.3%
Cerebral Haemorrhage 3.2%
Cholecystitis 3.2%
Dermatitis Exfoliative 3.2%
Pneumonia 3.2%
Pulmonary Haemorrhage 3.2%
Systemic Candida 3.2%
Weight Decreased 3.2%
Concomitant
Acute Myeloid Leukaemia 35.3%
Drug Use For Unknown Indication 7.7%
Product Used For Unknown Indication 7.7%
Acute Leukaemia 4.8%
Prophylaxis Against Graft Versus Host Disease 4.8%
Surgical Preconditioning 4.8%
Bone Marrow Transplant 3.9%
Breast Cancer In Situ 3.9%
Bone Marrow Conditioning Regimen 3.4%
Prophylaxis 3.4%
Acute Promyelocytic Leukaemia 2.9%
Wound Complication 2.9%
Acute Myeloblastic Leukemia 2.4%
Supplementation Therapy 2.4%
Hyperuricaemia 1.9%
Leukaemia 1.9%
Prophylaxis Of Nausea And Vomiting 1.9%
Antifungal Prophylaxis 1.4%
Skin Lesion 1.4%
Affective Disorder 1.0%
Cerebellar Syndrome 7.4%
Cytolytic Hepatitis 7.4%
Drug Ineffective 7.4%
Encephalitis 7.4%
Hepatocellular Injury 7.4%
Pericarditis Infective 7.4%
Spinal Disorder 7.4%
Abdominal Compartment Syndrome 3.7%
Acute Lymphocytic Leukaemia Recurrent 3.7%
Bradycardia 3.7%
Fasciitis 3.7%
Gene Mutation 3.7%
Graft Versus Host Disease 3.7%
Ileus Paralytic 3.7%
Nausea 3.7%
Pancreatitis Acute 3.7%
Paraparesis 3.7%
Post Procedural Complication 3.7%
Quadriplegia 3.7%
Relapsing Fever 3.7%